表紙:バイオセンサー市場:世界の業界動向、シェア、規模、成長、機会、予測(2021年~2026年)
市場調査レポート
商品コード
1037257

バイオセンサー市場:世界の業界動向、シェア、規模、成長、機会、予測(2021年~2026年)

Biosensors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 146 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.85円
バイオセンサー市場:世界の業界動向、シェア、規模、成長、機会、予測(2021年~2026年)
出版日: 2021年11月10日
発行: IMARC Services Private Limited
ページ情報: 英文 146 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のバイオセンサーの市場規模は、2015年~2020年にかけて力強い成長を示しました。同市場は今後、2021年~2026年の間に約8%のCAGRで拡大すると予測されています。

世界的に医療産業が大きく成長していることが、この市場の見通しを良くする主な要因の一つです。さらに、患者、乳幼児、子供、アスリート、フィットネス愛好家などのバイタルサインを継続的にモニタリングするために、ウェアラブルバイオセンサーが広く採用されていることも、市場成長の後押しとなっています。これらのバイオセンサーは、個人の遠隔モニタリングを容易にし、生物学的データを医師に送信してリアルタイムに警告を発することができます。また、バイオセンサーはスマートテキスタイルに組み込まれ、バイタルサインの追跡に便利です。これに伴い、コロナウイルス(COVID-19)の感染が拡大し続けていることから、医療機関では患者を継続的に監視するためのバイオセンサーの需要が大幅に増加しています。さらに、IoTによる接続機器の統合や、ナノテクノロジーを駆使した革新的なバイオセンサーの開発など、さまざまな技術的進歩も成長を促す要因として作用しています。

当レポートでは、世界のバイオセンサー市場について調査し、市場の概要とともに、製品別、テクノロジー別、用途別、最終用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のバイオセンサー市場

  • 市場概要
  • 市場実績
  • COVID-19の影響

第6章 市場の内訳、製品別

  • ウェアラブルバイオセンサー
  • 非ウェアラブルバイオセンサー

第7章 市場の内訳、テクノロジー別

  • 電気化学バイオセンサー
  • 光学バイオセンサー
  • 圧電バイオセンサー
  • サーマルバイオセンサー
  • ナノメカニカルバイオセンサー
  • その他

第8章 市場の内訳、用途別

  • 血糖値検査
  • コレステロール検査
  • 血液ガス分析
  • 妊娠検査
  • 創薬
  • 感染症検査
  • その他

第9章 市場の内訳、最終用途別

  • ポイントオブケア検査
  • 在宅ヘルスケア診断
  • 研究機関
  • セキュリティと生物兵器防衛
  • その他

第10章 市場の内訳、地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 国別の市場の内訳

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • AgaMatrix Inc.(WaveForm Technologies Inc)
    • DuPont de Nemours Inc.
    • F. Hoffmann-La Roche AG
    • General Electric Company
    • LifeScan Inc.(Platinum Equity LLC)
    • Medtronic PLC
    • Nova Biomedical Corporation
    • PHC Holdings Corporation
    • Siemens AG
    • Thermo Fisher Scientific Inc.
目次
Product Code: SR1020G278_Report

The global biosensors market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use industries. These insights are included in the report as a major market contributor.

A biosensor, or biological sensor, is an analytical device used to detect changes in various biological processes and convert them into an electrical signal. It is used for monitoring biological elements, such as enzymes, nucleic acids, tissues, cell receptors, microorganisms and antibodies. Some of the commonly used biosensors include mass, optical, electrochemical, magnetic, nanomechanical, thermometric, acoustic and immunosensors. They consist of a responsive sensor, transducer, microcontroller, signal conditioning circuit and display unit and are embedded in resonant mirrors, chemical canaries, optodes, bio-computers, biochips and glucometers. Biosensors are extensively used for point-of-care (POC) diagnostics, research, environmental monitoring and biodefense applications.

Biosensors Market Trends:

  • Significant growth in the medical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, widespread adoption of wearable biosensors for continuous monitoring of vital signs of patients, infants, children, athletes and fitness enthusiasts is providing a thrust to the market growth. These biosensors facilitate remote monitoring of the individuals and can transmit biological data to the physician for real-time alerts. They are also incorporated in smart textiles for convenient tracking of vital signs. In line with this, as the coronavirus disease (COVID-19) continues to spread, there has been a substantial increase in the demand for biosensors in the healthcare centers for continuous monitoring of the patients. Additionally, various technological advancements, such as the integration of connected devices with the Internet of Things (IoT) and the development of innovative nanotechnology-based biosensors, are acting as other growth-inducing factors. These biosensors are used in nanotubes, nanowires, nanorods and nanoparticles for biomolecular detection. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global biosensors market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, technology, application and end use.

Breakup by Product:

  • Wearable Biosensors
  • Non-Wearable Biosensors

Breakup by Technology:

  • Electrochemical Biosensors
  • Optical Biosensors
  • Piezoelectric Biosensors
  • Thermal Biosensors
  • Nanomechanical Biosensors
  • Others

Breakup by Application:

  • Blood Glucose Testing
  • Cholesterol Testing
  • Blood Gas Analysis
  • Pregnancy Testing
  • Drug Discovery
  • Infectious Disease Testing
  • Others

Breakup by End Use:

  • Point of Care Testing
  • Home Healthcare Diagnostics
  • Research Laboratories
  • Security and Biodefense
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AgaMatrix Inc. (WaveForm Technologies Inc), DuPont de Nemours Inc., F. Hoffmann-La Roche AG, General Electric Company, LifeScan Inc. (Platinum Equity LLC), Medtronic PLC, Nova Biomedical Corporation, PHC Holdings Corporation, Siemens AG and Thermo Fisher Scientific Inc. Key Questions Answered in This Report:

  • How has the global biosensors market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global biosensors market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global biosensors market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biosensors Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Wearable Biosensors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-Wearable Biosensors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Electrochemical Biosensors
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Optical Biosensors
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Piezoelectric Biosensors
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Thermal Biosensors
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Nanomechanical Biosensors
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Blood Glucose Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cholesterol Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Blood Gas Analysis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pregnancy Testing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Drug Discovery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Infectious Disease Testing
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Point of Care Testing
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Home Healthcare Diagnostics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Security and Biodefense
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 AgaMatrix Inc. (WaveForm Technologies Inc)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 DuPont de Nemours Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 General Electric Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 LifeScan Inc. (Platinum Equity LLC)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Medtronic PLC
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Nova Biomedical Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 PHC Holdings Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Siemens AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis